Small-cell lung cancer (SCLC) is the most aggressive lung cancer subtype and lacks effective early detection methods and therapies. timing of autoantibody development relative to malignancy and the nature of the immune trigger remain to be elucidated. Here we review what is currently known about SCLC-associated autoantibodies and describe a recently developed mouse model system… Continue reading Small-cell lung cancer (SCLC) is the most aggressive lung cancer subtype